0000905718-14-000315.txt : 20140529 0000905718-14-000315.hdr.sgml : 20140529 20140529174748 ACCESSION NUMBER: 0000905718-14-000315 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140529 FILED AS OF DATE: 20140529 DATE AS OF CHANGE: 20140529 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGILE THERAPEUTICS INC CENTRAL INDEX KEY: 0001261249 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 101 POOR FARM ROAD CITY: PRINCETON STATE: NJ ZIP: 08540-1715 BUSINESS PHONE: 609-683-1880 MAIL ADDRESS: STREET 1: 101 POOR FARM ROAD CITY: PRINCETON STATE: NJ ZIP: 08540-1715 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: INVESTOR AB CENTRAL INDEX KEY: 0000889232 STATE OF INCORPORATION: V7 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36464 FILM NUMBER: 14877268 BUSINESS ADDRESS: STREET 1: ARSENALSGATAN 8C STREET 2: SE-103 32 CITY: STOCKHOLM STATE: V7 ZIP: 00000 BUSINESS PHONE: 46-8-6142000 MAIL ADDRESS: STREET 1: ARSENALSGATAN 8C STREET 2: SE-103 32 CITY: STOCKHOLM STATE: V7 ZIP: 00000 4 1 agile_form4may292014.xml OWNERSHIP DOCUMENT X0306 4 2014-05-29 0 0001261249 AGILE THERAPEUTICS INC AGRX 0000889232 INVESTOR AB C/O INVESTOR GROWTH CAPITAL, LLC ONE ROCKEFELLER PLAZA, SUITE 2801 NEW YORK NY 10020 0 0 1 0 Common Stock, par value $0.0001 per share 2014-05-29 4 P 0 2509949 6.00 A 3509949 I See Footnotes As of May 29, 2014 (the "Filing Date"), certain affiliated entities of Investor AB, a publicly held Swedish company (the "Reporting Person"), hold 3,509,949 shares of common stock, $0.0001 par value per share (the "Common Shares"), of Agile Therapeutics, Inc., a Delaware corporation (the "Company"). The Reporting Person, through one or more intermediate entities, previously held certain convertible securities which were automatically converted into 2,509,949 Common Shares upon the closing of the Company's initial public offering. As a result of the foregoing, the Reporting Person, through one or more intermediate entities, possesses the sole power to vote and the sole power to direct the disposition of the Common Shares reported herein. Accordingly, the Reporting Person, as of the Filing Date, may be deemed to beneficially own 3,509,949 Common Shares. The Reporting Person interest in the Common Shares reported herein is limited to its pecuniary interest, if any, in such Common Shares. Investor AB /s/ Michael V. Oporto, Authorized Signatory 2014-05-29